Bevantolol Hydrochloride is a cardioselective beta-1 adrenergic blocker used for hypertension and angina, predominantly in Asian markets. Simson Pharma's Bevantolol Hydrochloride reference standard supports compendial QC for this cardiovascular therapeutic.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bevantolol hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.